Aker BioMarine ASA (OSL:AKBM) ROE % Adjusted to Book Value : -8.89% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA ROE % Adjusted to Book Value?

Aker BioMarine ASA's ROE % for the quarter that ended in Mar. 2024 was -13.24%. Aker BioMarine ASA's PB Ratio for the quarter that ended in Mar. 2024 was 1.49. Aker BioMarine ASA's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -8.89%.

Aker BioMarine ASA ROE % Adjusted to Book Value Historical Data

The historical data trend for Aker BioMarine ASA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA ROE % Adjusted to Book Value Chart

Aker BioMarine ASA Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-0.65

-1.52

3.13

-2.40

Aker BioMarine ASA Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-21.73	-3.51	1.38	10.44	-8.89

Competitive Comparison of Aker BioMarine ASA's ROE % Adjusted to Book Value

For the Packaged Foods subindustry, Aker BioMarine ASA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aker BioMarine ASA's ROE % Adjusted to Book Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's ROE % Adjusted to Book Value falls into.

Aker BioMarine ASA ROE % Adjusted to Book Value Calculation

Aker BioMarine ASA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-2.50%	/	1.04
	=	-2.40%

Aker BioMarine ASA's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-13.24%	/	1.49
	=	-8.89%

Aker BioMarine ASA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Aker BioMarine ASA (OSL:AKBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

1PG:Germany

Address

Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327

Website

https://www.akerbiomarine.com

Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines